BRIEF-Lattice Semiconductor Considers Offer For Intel's Altera Unit- Bloomberg News-February 2024-www.financetom.com

BRIEF-Lattice Semiconductor Considers Offer For Intel's Altera Unit- Bloomberg News

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Lattice Semiconductor Considers Offer For Intel's Altera Unit- Bloomberg News

Nov 22, 2024 4:33 PM

Nov 22 (Reuters) -

* LATTICE SEMICONDUCTOR CONSIDERS OFFER FOR INTEL'S ALTERA

UNIT-

BLOOMBERG NEWS

Source https://tinyurl.com/5e3b9z9j

Previous page： U.S. opens probe into over 129,000 Ford vehicles over hands-free tech Next page： PostNL calls for 'urgent' government action after 2024 profit warning

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

U.S. opens probe into over 129,000 Ford vehicles over hands-free tech

Jan 20, 2025

Jan 20 (Reuters) - The National Highway Traffic Safety Administration said on Monday it has opened a probe into 129,222 Ford Motor ( F ) vehicles over reports of collisions involving the company's hands-free driving technology, BlueCruise. ...

PostNL calls for 'urgent' government action after 2024 profit warning

Jan 20, 2025

Jan 20 (Reuters) - PostNL's chief executive called for urgent government action to safeguard the Dutch postal service on Monday, after the group warned on 2024 profit partly due to what she called an unsustainable business model. Shares of the postal operator fell as much as 8.4% in early trading, nearing their all-time low seen in March 2020. Slow to...

Mitsubishi Chemical has given Bain right of first refusal to negotiate sale of its subsidiary, Nikkei says

Jan 20, 2025

TOKYO, Jan 20 (Reuters) - Mitsubishi Chemical Group ( MTLHF ) has given the U.S. investment fund Bain Capital the right of first refusal to negotiate the sale of its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the Nikkei reported on Monday. ...

Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says

Jan 20, 2025

TOKYO, Jan 20 (Reuters) - Mitsubishi Chemical Group ( MTLHF ) has given the U.S. investment fund Bain Capital the right of first refusal to negotiate the purchase of its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the Nikkei reported on Monday. Mitsubishi Chemical ( MTLHF ) is likely to sell Tanabe Mitsubishi Pharma to Bain Capital for more than 500 billion...